Wells Fargo & Company Kempharm, Inc Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KMPH
# of Institutions
97Shares Held
15.8MCall Options Held
170KPut Options Held
38.5K-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.42MShares$12 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$9.06 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY1.16MShares$5.74 Million3.06% of portfolio
-
Woodline Partners LP San Francisco, CA1.15MShares$5.67 Million0.06% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...